drugset / Trial / NCT06860399

Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn

NCT06860399

Phase 1/2 Completed 55 enrolled Damascus University
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to learn if drug Vardenafil works to treat pulmonary hypertension in newborns, It will also learn about the safety of Vardenafil. The main questions it aims to answer are: Does Vardenafil lower the pulmonary hypertension in newborns? What medical problems do participants have when taking Vardenafil? Researchers will compare drug Vardenafil to drug Sildenafil to see if drug Vardenafil works better to treat pulmonary hypertension. Participants will be divided into 2 groups , one group will take oral drug: Vardenafil and the other group will take oral drug: Sildenafil every day. Pulmonary hypertension will be measured daily until it returns to normal. Keep a diary of the symptoms and any complications

Timeline

Start
2023-05-01
Primary completion
2024-09-30
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown Oral
Subject Vardenafil Small molecule Oral